Association of upper and lower airway eosinophilic inflammation with response to omalizumab in patients with severe asthma-Reference-Cited by-同舟云学术

Association of upper and lower airway eosinophilic inflammation with response to omalizumab in patients with severe asthma

Published:2018-11-29 Issue:1 Volume:57 Page:71-78
ISSN:0277-0903
Container-title:Journal of Asthma
language:en
Short-container-title:Journal of Asthma

Author:

Kurokawa Makoto¹,Koya Toshiyuki¹,Takeuchi Hiroyuki¹,Hayashi Masachika¹,Sakagami Takuro¹,Ishioka Kojiro²,Gon Yasuhiro³,Hasegawa Takashi⁴,Kikuchi Toshiaki¹

Affiliation:

1. Department of Respiratory Medicine and Infectious Diseases, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan;

2. Department of Otolaryngology Head and Neck Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan;

3. Division of Respiratory Medicine, Department of Internal Medicine, Nihon University of Medicine, Tokyo, Japan;

4. Department of General Medicine, Niigata University Medical and Dental Hospital, Japan, Niigata

Publisher

Informa UK Limited

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Pediatrics, Perinatology and Child Health

Link

https://www.tandfonline.com/doi/pdf/10.1080/02770903.2018.1541357

Reference24 articles.

1. Pathophysiology of severe asthma

2. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

3. Predicting and evaluating response to omalizumab in patients with severe allergic asthma

4. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Interaction between Fractional Exhaled Nitric Oxide and Biologic Treatment in Severe Asthma: A Systematic Review;Antioxidants;2023-02-07

2. Fractional nitric oxide measurement in exhaled air (FeNO): perspectives in the management of respiratory diseases;Therapeutic Advances in Chronic Disease;2023-01

3. Predictive biomarkers for response to omalizumab in patients with severe allergic asthma: a meta-analysis;Expert Review of Respiratory Medicine;2022-06-23

4. Understanding the Cellular Sources of the Fractional Exhaled Nitric Oxide (FeNO) and Its Role as a Biomarker of Type 2 Inflammation in Asthma;BioMed Research International;2022-05-02

5. The Role of IgE in Upper and Lower Airway Disease: More Than Just Allergy!;Clinical Reviews in Allergy & Immunology;2021-09-18